Roche Roche Nabs CE Mark for Three Cobas Respiratory Test Panels The molecular panels, which can be run together or alone, detect and differentiate between common respiratory pathogens. Roche to Acquire TIB Molbiol to Expand Infectious Disease Test Portfolio TIB Molbiol already has more than 45 CE-marked tests available on Roche's LightCycle PCR instruments and its MagNA Pure sample prep systems. Roche Reports Diagnostics Revenue Up 51 Percent in H1 Continued interest in COVID-19 products, as well as recoveries in the firm's base businesses, drove growth in the diagnostics division. Hyrax Biosciences, Roche Diagnostics Form SARS-CoV-2 Sequencing Tech Alliance The companies will offer Hyrax's Exatype DNA analysis platform alongside Roche's research-use-only KAPA HyperCap SARS-CoV-2 panel. Roche, Mimetas Partner to Develop Disease Models for Drug Discovery The companies are doing research to characterize novel drug compounds in inflammatory bowel disease and hepatitis B virus. Jul 1, 2021 FDA Approves FoundationOne CDx for Takeda's ALK-Inhibitor Jun 18, 2021 Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Jun 18, 2021 Natera Aims to Lead Market in Solid Tumor Adjuvant CDx, Supported by New Liquid Biopsy Data Premium May 28, 2021 Roche, Canadian Organizations Launch Real-World Evidence Framework in British Columbia May 26, 2021 Illumina, Roche Agree to Settle NIPT Patent Lawsuits Apr 21, 2021 Roche Diagnostics Q1 Sales Climb 50 Percent Apr 13, 2021 FDA-Led Group Evaluates Performance of RUO Liquid Biopsy Assays to Inform Practice Guidelines Premium Apr 6, 2021 Roche to Use Oncimmune Infectious Disease Panel in COVID-19 Drug Trial Mar 19, 2021 New Products Posted to GenomeWeb: Roche, Twist Bioscience, Codex DNA, More Mar 16, 2021 Looking Beyond Pandemic, Roche Eyes Growing Opportunities for Dx Testing Premium Mar 15, 2021 Roche to Acquire GenMark Diagnostics for $1.8B Mar 12, 2021 FDA Warns of Potential False Positive Results With Roche Cobas Liat Rapid SARS-CoV-2, Flu Test Mar 11, 2021 Roche Cobas HIV, Hepatitis C Tests Nab WHO Prequalification Mar 8, 2021 Bio-Rad Laboratories, Roche Enter Quality Control Partnership Feb 18, 2021 WHO Finds High Diagnostic Accuracy in Three Classes of MDx Technologies for TB Testing, Resistance Feb 11, 2021 Roche Receives FDA Clearance for Cobas BKV Test for Use With Urine Samples Feb 4, 2021 Roche Diagnostics Expanding Manufacturing Capacity, Testing Portfolio in 2021 Premium Feb 4, 2021 Roche Diagnostics Revenues Increase 6 Percent in 2020 Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher Dec 18, 2020 UK Launches Public-Private iDx-Lung Consortium to Improve Early Detection of Lung Cancers Load More Breaking News LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design NIH Awards $73M to Continue Buildout of ClinGen Zymo Research Gets CE Mark for DNA Methylation Kit PhenoBiome Inks US Distribution Deal With Genetic Direction for Gut Microbiome Assay Service The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.